首页 > 最新文献

Techniques and Innovations in Gastrointestinal Endoscopy最新文献

英文 中文
Endoscopic Band Ligation With Sclerotherapy Versus Milligan–Morgan Hemorrhoidectomy for the Treatment of Mixed Hemorrhoids 治疗混合痔的内窥镜带状结扎术和硬化疗法与米利根-摩根痔疮切除术的比较
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-01-31 DOI: 10.1016/j.tige.2025.250914
Minghua Ai , Weizheng Wang , Jie Li , Xiaoping Tan , Qing Zhang

BACKGROUND AND AIMS

To compare the clinical efficacy of endoscopic band ligation with sclerotherapy (EBS) with that of Milligan–Morgan hemorrhoidectomy (MMH) in the treatment of mixed hemorrhoids.

METHODS

This study was a retrospective, single-center investigation conducted at the First Hospital of Yangtze University. From September 2022 to March 2023, 46 patients who underwent EBS for mixed hemorrhoids were selected in an observation group, whereas 32 patients who underwent MMH for mixed hemorrhoids were allocated to a control group. Surgical-related parameters and adverse events were compared between the 2 groups, and the relationship between the number of endoscopic bands used and pain levels was analyzed.

RESULTS

The observation group demonstrated significantly shorter surgical and hospitalization durations than the control group (P < 0.05). Furthermore, the 2 groups showed decreased postoperative visual analog scale scores, with the observation group exhibiting consistently lower scores at 24 hours, 48 hours, and 1 week postoperatively (P < 0.05). Additionally, visual analog scale scores in the observation group at 4 hour postsurgery were correlated with the number of endoscopic ligation bands applied (R2 = 0.1253; P = 0.0158). No significant differences in postoperative anal swelling, overall efficacy, or patient satisfaction were observed between the 2 groups (all P > 0.05). However, the observation group experienced significantly less intraoperative (0% vs 84.4%; P = 0.000) and postoperative bleeding (6.5% vs 34.4%; P = 0.002) and a lower postoperative infection rate (0% vs 9.4%; P = 0.034) than the control group.

CONCLUSION

EBS provides clinical efficacy comparable with that of MMH in the treatment of mixed hemorrhoids. Moreover, the EBS approach is a potentially less invasive and shorter surgical procedure with relatively reduced hospitalization time, lower complication risk, and faster recovery.
背景和目的比较内镜下带状结扎联合硬化剂注射(EBS)与米利根-摩根痔切除术(MMH)治疗混合痔的临床疗效。自2022年9月至2023年3月,46名接受EBS治疗混合痔的患者被选入观察组,32名接受MMH治疗混合痔的患者被分配到对照组。结果观察组的手术时间和住院时间明显短于对照组(P <0.05)。此外,两组的术后视觉模拟量表评分均有所下降,观察组在术后 24 小时、48 小时和 1 周的评分持续较低(P < 0.05)。此外,观察组在术后 4 小时的视觉模拟量表评分与使用的内窥镜结扎带数量相关(R2 = 0.1253;P = 0.0158)。两组患者在术后肛门肿胀、总体疗效或患者满意度方面无明显差异(均为 P > 0.05)。然而,观察组的术中出血量(0% vs 84.4%;P = 0.000)和术后出血量(6.5% vs 34.4%;P = 0.002)明显少于对照组,术后感染率(0% vs 9.4%;P = 0.034)也低于对照组。此外,EBS 方法可能是一种创伤更小、时间更短的手术方法,住院时间相对缩短,并发症风险更低,恢复更快。
{"title":"Endoscopic Band Ligation With Sclerotherapy Versus Milligan–Morgan Hemorrhoidectomy for the Treatment of Mixed Hemorrhoids","authors":"Minghua Ai ,&nbsp;Weizheng Wang ,&nbsp;Jie Li ,&nbsp;Xiaoping Tan ,&nbsp;Qing Zhang","doi":"10.1016/j.tige.2025.250914","DOIUrl":"10.1016/j.tige.2025.250914","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>To compare the clinical efficacy of endoscopic band ligation with sclerotherapy (EBS) with that of Milligan–Morgan hemorrhoidectomy (MMH) in the treatment of mixed hemorrhoids.</div></div><div><h3>METHODS</h3><div>This study was a retrospective, single-center investigation conducted at the First Hospital of Yangtze University. From September 2022 to March 2023, 46 patients who underwent EBS for mixed hemorrhoids were selected in an observation group, whereas 32 patients who underwent MMH for mixed hemorrhoids were allocated to a control group. Surgical-related parameters and adverse events were compared between the 2 groups, and the relationship between the number of endoscopic bands used and pain levels was analyzed.</div></div><div><h3>RESULTS</h3><div>The observation group demonstrated significantly shorter surgical and hospitalization durations than the control group (<em>P &lt;</em> 0.05). Furthermore, the 2 groups showed decreased postoperative visual analog scale scores, with the observation group exhibiting consistently lower scores at 24 hours, 48 hours, and 1 week postoperatively (<em>P &lt;</em> 0.05). Additionally, visual analog scale scores in the observation group at 4 hour postsurgery were correlated with the number of endoscopic ligation bands applied (<em>R</em><sup>2</sup> = 0.1253; <em>P</em> = 0.0158). No significant differences in postoperative anal swelling, overall efficacy, or patient satisfaction were observed between the 2 groups (all <em>P &gt;</em> 0.05). However, the observation group experienced significantly less intraoperative (0% vs 84.4%; <em>P</em> = 0.000) and postoperative bleeding (6.5% vs 34.4%; <em>P</em> = 0.002) and a lower postoperative infection rate (0% vs 9.4%; <em>P</em> = 0.034) than the control group.</div></div><div><h3>CONCLUSION</h3><div>EBS provides clinical efficacy comparable with that of MMH in the treatment of mixed hemorrhoids. Moreover, the EBS approach is a potentially less invasive and shorter surgical procedure with relatively reduced hospitalization time, lower complication risk, and faster recovery.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250914"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143687023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Endoscopic Role and Indications of Through-the-Scope Tack and Suture System for Gastrointestinal Closure 用于胃肠道缝合的镜下粘合剂和缝合系统的内窥镜作用和适应症
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-11 DOI: 10.1016/j.tige.2024.09.005
Andrew Canakis , Abdulhameed Al-Sabban , Shayan S. Irani
The development of endoscopic closure devices has revolutionized management options for gastrointestinal defects. The endoscopists’ toolbox has expanded from through-the-scope clips to over-the-scope clips and over-the-scope suturing. The over-the-scope devices are somewhat limited by the target location, maneuverability, and need for device withdrawal for application. The introduction of a novel through-the-scope helix tack suture system enhances the toolbox for defect closure as this device can provide closure throughout the gastrointestinal tract without the need for endoscope withdrawal. Its user-friendly design and compatibility with standard endoscopes allows for complex tissues approximation in challenging locations. Since its approval by the Federal Drug Agency in December 2020, studies have investigated its utility for all types of defects, including perforations, leaks, fistulas, endoscopic resections sites, and even stent fixation. In this review, we will investigate the versatility of this device to understand its role in primary defect closure.
内窥镜闭合装置的发展彻底改变了胃肠道缺损的治疗方案。内镜医师的工具箱从镜下夹扩大到镜上夹和镜下缝合。由于目标位置、可操作性和应用时需要拔出器械等原因,镜下器械在一定程度上受到了限制。新型镜下螺旋粘合缝合系统的引入增强了缺陷缝合的工具箱,因为这种装置可以在整个胃肠道内进行缝合,而无需撤出内窥镜。它的设计方便用户使用,并与标准内窥镜兼容,可在具有挑战性的位置对复杂组织进行近似缝合。自 2020 年 12 月获得联邦药品管理局批准以来,已有研究对其在各种类型的缺陷中的实用性进行了调查,包括穿孔、渗漏、瘘管、内镜切除部位,甚至支架固定。在这篇综述中,我们将研究这种装置的多功能性,以了解它在初级缺陷闭合中的作用。
{"title":"The Endoscopic Role and Indications of Through-the-Scope Tack and Suture System for Gastrointestinal Closure","authors":"Andrew Canakis ,&nbsp;Abdulhameed Al-Sabban ,&nbsp;Shayan S. Irani","doi":"10.1016/j.tige.2024.09.005","DOIUrl":"10.1016/j.tige.2024.09.005","url":null,"abstract":"<div><div>The development of endoscopic closure devices has revolutionized management options for gastrointestinal defects. The endoscopists’ toolbox has expanded from through-the-scope clips to over-the-scope clips and over-the-scope suturing. The over-the-scope devices are somewhat limited by the target location, maneuverability, and need for device withdrawal for application. The introduction of a novel through-the-scope helix tack suture system enhances the toolbox for defect closure as this device can provide closure throughout the gastrointestinal tract without the need for endoscope withdrawal. Its user-friendly design and compatibility with standard endoscopes allows for complex tissues approximation in challenging locations. Since its approval by the Federal Drug Agency in December 2020, studies have investigated its utility for all types of defects, including perforations, leaks, fistulas, endoscopic resections sites, and even stent fixation. In this review, we will investigate the versatility of this device to understand its role in primary defect closure.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 150898"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142704852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Ultrasound-Guided Pancreatic Fluid Collection Drainage and Pancreatic Ductal Drainage 超声内镜引导下胰液收集引流及胰管引流
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-15 DOI: 10.1016/j.tige.2025.250921
Sridhar Sundaram , Surinder Singh Rana
Peripancreatic fluid collections (PFCs) are common complications associated with acute and chronic pancreatitis. Symptomatic PFCs need drainage, and endoscopic ultrasound (EUS) is the current standard of care. Various factors like the size, location, presence of debris in the collection, and general condition of the patient drive the choice of technique for EUS-guided transmural PFC drainage. While plastic stents were initially used, specially designed lumen-apposing and biflanged metal stents have revolutionized therapy for pancreatic necrotic collections. Minimally invasive approach in the form of endoscopic necrosectomy is now established as part of the step-up approach for performing debridement. PFCs are also often associated with disconnected pancreatic duct, which is a difficult situation to manage with evolving evidence. Pancreatic ductal obstruction due to strictures and stones represent indications for endoscopic intervention with stent placement to reduce ductal hypertension. EUS-guided pancreatic duct drainage represents an alternative in patients where endoscopic retrograde cholangiopancreatography fails or is not feasible. Either transmural or transpapillary approaches have been described. In this review, we discuss the role of EUS in drainage of PFCs along with technical tips for the same. We also discuss in detail technical steps and accessories and provide a critical appraisal on evidence for EUS-guided pancreatic duct drainage.
胰周积液(pfc)是急性和慢性胰腺炎的常见并发症。有症状的PFCs需要引流,内镜超声(EUS)是目前的标准治疗方法。各种因素,如大小、位置、收集物中碎片的存在以及患者的一般情况,决定了eus引导下经壁PFC引流技术的选择。虽然最初使用的是塑料支架,但专门设计的腔旁置和双法兰金属支架已经彻底改变了胰腺坏死集合的治疗方法。以内窥镜坏死切除术形式的微创入路现已被确立为进行清创的升级入路的一部分。pfc也经常与胰管断开有关,随着证据的不断发展,这是一个难以处理的情况。胰腺导管狭窄和结石引起的梗阻是内镜下支架置入术降低导管高血压的指征。eus引导胰管引流是内镜逆行胰胆管造影失败或不可行的患者的一种选择。经壁入路或经乳头入路均有报道。在这篇综述中,我们讨论了EUS在pfc引流中的作用以及技术提示。我们还详细讨论了技术步骤和附件,并对eus引导胰管引流的证据进行了批判性评估。
{"title":"Endoscopic Ultrasound-Guided Pancreatic Fluid Collection Drainage and Pancreatic Ductal Drainage","authors":"Sridhar Sundaram ,&nbsp;Surinder Singh Rana","doi":"10.1016/j.tige.2025.250921","DOIUrl":"10.1016/j.tige.2025.250921","url":null,"abstract":"<div><div>Peripancreatic fluid collections (PFCs) are common complications associated with acute and chronic pancreatitis. Symptomatic PFCs need drainage, and endoscopic ultrasound (EUS) is the current standard of care. Various factors like the size, location, presence of debris in the collection, and general condition of the patient drive the choice of technique for EUS-guided transmural PFC drainage. While plastic stents were initially used, specially designed lumen-apposing and biflanged metal stents have revolutionized therapy for pancreatic necrotic collections. Minimally invasive approach in the form of endoscopic necrosectomy is now established as part of the step-up approach for performing debridement. PFCs are also often associated with disconnected pancreatic duct, which is a difficult situation to manage with evolving evidence. Pancreatic ductal obstruction due to strictures and stones represent indications for endoscopic intervention with stent placement to reduce ductal hypertension. EUS-guided pancreatic duct drainage represents an alternative in patients where endoscopic retrograde cholangiopancreatography fails or is not feasible. Either transmural or transpapillary approaches have been described. In this review, we discuss the role of EUS in drainage of PFCs along with technical tips for the same. We also discuss in detail technical steps and accessories and provide a critical appraisal on evidence for EUS-guided pancreatic duct drainage.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250921"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144107474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Sleeve Gastroplasty Reduces Atherosclerotic Cardiovascular Disease Risk: A Cohort Study Using Pooled Cohort Equations and Predicting Risk of Cardiovascular Disease Events Models 内镜下套筒胃成形术降低动脉粥样硬化性心血管疾病风险:一项使用合并队列方程和预测心血管疾病事件模型的队列研究
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-08-08 DOI: 10.1016/j.tige.2025.250942
Ali Lahooti , Chino Aneke-Nash , Kate E. Johnson , Anam Rizvi , Muhammad U. Baig , Alpana Shukla , Carolyn Newberry , Emily Smith , Jude M. Sharaiha , Mark Hanscom , Kartik Sampath , David L. Carr-Locke , SriHari Mahadev , Sonal Kumar , Robert Schwartz , Samuel M. Kim , Reem Z. Sharaiha

BACKGROUND AND AIMS

Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure for obesity, a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, its impact on cardiovascular risk remains underexplored. This study evaluates ESG’s effects on ASCVD risk and obesity-related comorbidities.

METHODS

In this cohort study, 168 adults with obesity (aged 30-79 years; body mass index, ≥30 kg/m2 or ≥27 kg/m2; with comorbidities) underwent ESG at a single tertiary care facility from 2013 to 2024. Patients were evaluated at baseline and 12 months after procedure using the Pooled Cohort Equations (PCEs) for patients aged 40-79 years and the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations for those aged 30-79 years. Changes in body weight, glycemic control, blood pressure, lipid profile (total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides), and liver enzymes (alanine aminotransferase) were also analyzed.

RESULTS

Of the 168 patients (median age, 48 years; 74% female; body mass index, 36.0 kg/m2), 129 and 159 met inclusion criteria for PCEs and PREVENT equations, respectively. At 12 months, median PCEs ASCVD risk score decreased from 3.3% to 3.0% (21% reduction, P < 0.001), while the PREVENT 10-year cardiovascular disease risk score declined from 3.1% to 2.4% (20% reduction; P < 0.001), with similar reductions in 30-year risk scores and greater improvements in high/intermediate-risk patients and those aged >50 years. Patients achieved a median total body weight loss of 13.5% (IQR, 8.1%-18.6%), with significant metabolic improvements, and >80% experienced diabetes resolution. There was 1 (0.6%) moderate adverse event.

CONCLUSION

Adults who underwent ESG showed significant improvements in ASCVD risk and obesity-related comorbidities at 12 months after procedure. These findings suggest that ESG may be an effective intervention for managing obesity and mitigating cardiovascular risk in patients with obesity. ClincialTrials.gov identifier: NCT04494048.
背景:aimsenscopic sleeve gastroplasty (ESG)是一种治疗肥胖的微创手术,肥胖是动脉粥样硬化性心血管疾病(ASCVD)的危险因素。然而,其对心血管风险的影响仍未得到充分探讨。本研究评估ESG对ASCVD风险和肥胖相关合并症的影响。方法在这项队列研究中,168名肥胖成人(年龄30-79岁,体重指数≥30 kg/m2或≥27 kg/m2,有合并症)于2013年至2024年在一家三级医疗机构接受了ESG检查。在基线和手术后12个月,对40-79岁的患者使用合并队列方程(pce),对30-79岁的患者使用心血管疾病事件预测风险方程(prevention)进行评估。还分析了体重、血糖控制、血压、血脂(总胆固醇、低脂蛋白和高密度脂蛋白胆固醇、甘油三酯)和肝酶(丙氨酸转氨酶)的变化。结果168例患者(中位年龄48岁,女性占74%,体重指数36.0 kg/m2),分别有129例和159例符合pce和PREVENT方程的纳入标准。在12个月时,PCEs ASCVD风险评分中位数从3.3%下降到3.0%(降低21%,P < 0.001),而prevention 10年心血管疾病风险评分从3.1%下降到2.4%(降低20%,P < 0.001), 30年风险评分也有类似的降低,高/中危患者和50岁患者的改善更大。患者的中位总体重减轻13.5% (IQR, 8.1%-18.6%),代谢显著改善,80%的患者糖尿病得到缓解。有1例(0.6%)中度不良事件。结论:接受ESG的成年人在手术后12个月ASCVD风险和肥胖相关合并症有显著改善。这些发现表明,ESG可能是控制肥胖和减轻肥胖患者心血管风险的有效干预措施。ClincialTrials.gov识别码:NCT04494048。
{"title":"Endoscopic Sleeve Gastroplasty Reduces Atherosclerotic Cardiovascular Disease Risk: A Cohort Study Using Pooled Cohort Equations and Predicting Risk of Cardiovascular Disease Events Models","authors":"Ali Lahooti ,&nbsp;Chino Aneke-Nash ,&nbsp;Kate E. Johnson ,&nbsp;Anam Rizvi ,&nbsp;Muhammad U. Baig ,&nbsp;Alpana Shukla ,&nbsp;Carolyn Newberry ,&nbsp;Emily Smith ,&nbsp;Jude M. Sharaiha ,&nbsp;Mark Hanscom ,&nbsp;Kartik Sampath ,&nbsp;David L. Carr-Locke ,&nbsp;SriHari Mahadev ,&nbsp;Sonal Kumar ,&nbsp;Robert Schwartz ,&nbsp;Samuel M. Kim ,&nbsp;Reem Z. Sharaiha","doi":"10.1016/j.tige.2025.250942","DOIUrl":"10.1016/j.tige.2025.250942","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure for obesity, a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, its impact on cardiovascular risk remains underexplored. This study evaluates ESG’s effects on ASCVD risk and obesity-related comorbidities.</div></div><div><h3>METHODS</h3><div>In this cohort study, 168 adults with obesity (aged 30-79 years; body mass index, ≥30 kg/m<sup>2</sup> or ≥27 kg/m<sup>2</sup>; with comorbidities) underwent ESG at a single tertiary care facility from 2013 to 2024. Patients were evaluated at baseline and 12 months after procedure using the Pooled Cohort Equations (PCEs) for patients aged 40-79 years and the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations for those aged 30-79 years. Changes in body weight, glycemic control, blood pressure, lipid profile (total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides), and liver enzymes (alanine aminotransferase) were also analyzed.</div></div><div><h3>RESULTS</h3><div>Of the 168 patients (median age, 48 years; 74% female; body mass index, 36.0 kg/m<sup>2</sup>), 129 and 159 met inclusion criteria for PCEs and PREVENT equations, respectively. At 12 months, median PCEs ASCVD risk score decreased from 3.3% to 3.0% (21% reduction, <em>P</em> &lt; 0.001), while the PREVENT 10-year cardiovascular disease risk score declined from 3.1% to 2.4% (20% reduction; <em>P</em> &lt; 0.001), with similar reductions in 30-year risk scores and greater improvements in high/intermediate-risk patients and those aged &gt;50 years. Patients achieved a median total body weight loss of 13.5% (IQR, 8.1%-18.6%), with significant metabolic improvements, and &gt;80% experienced diabetes resolution. There was 1 (0.6%) moderate adverse event.</div></div><div><h3>CONCLUSION</h3><div>Adults who underwent ESG showed significant improvements in ASCVD risk and obesity-related comorbidities at 12 months after procedure. These findings suggest that ESG may be an effective intervention for managing obesity and mitigating cardiovascular risk in patients with obesity. ClincialTrials.gov identifier: NCT04494048.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 4","pages":"Article 250942"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traction-Assisted Endoscopic Submucosal Dissection of Colonic Lesions: A North American Experience 牵引辅助内镜下结肠病变粘膜剥离:北美经验
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-07 DOI: 10.1016/j.tige.2024.250900
Farid Abushamat, Fares Ayoub, Mai A. Khalaf, Tara Keihanian, Salmaan Jawaid, Mohamed O. Othman

BACKGROUND AND AIMS

Traction-assisted endoscopic submucosal dissection (TA-ESD) is a proposed technique to improve the efficiency of endoscopic submucosal dissection (ESD). Multiple studies primarily from Asian centers yielded mixed results in terms of procedure time, en bloc resection rate, and R0 resection rate of TA-ESD in comparison with those of conventional endoscopic submucosal dissection (C-ESD). We performed the first comparison of TA-ESD with C-ESD at a high-volume North American center.

METHODS

This was a retrospective cohort-matched study of all patients who underwent colonic ESD at a single center in the United States by a single operator. The study group were patients who underwent TA-ESD and were matched with a C-ESD case on a 1:1 basis based upon location within the colon, lesion size, and scope stabilization device usage. The baseline characteristics and procedure-related outcomes were compared between the groups.

RESULTS

In total, 138 colonic ESD cases were included (69 TA-ESD and 69 C-ESD). There were no significant differences in the baseline characteristics between the groups. Mean procedure time was 91.0 minutes (SD: 32.5) for TA-ESD and 85.4 minutes (SD: 39.3) for C-ESD (P = 0.36). En bloc resection was achieved in 69 (100%) of the TA-ESDs and 67 (97.1%) of the C-ESDs (P = 0.15). R0 resection was achieved in 52 (75.4%) of the TA-ESDs and 48 (69.6%) of the C-ESDs (P = 0.45).

CONCLUSION

We did not show a significant difference in procedure time, en bloc resection, R0 resection, or adverse events. Further randomized prospective studies that are sufficiently powered and stratified by operator experience level are needed to further elucidate the utility of the technique.
背景和目的超声辅助内镜下粘膜剥离术(TA-ESD)是一种提高内镜下粘膜剥离术(ESD)效率的技术。主要来自亚洲中心的多项研究在手术时间、整体切除率和R0切除率方面与传统内镜下粘膜下剥离(C-ESD)相比得出了不同的结果。我们在北美大容量中心进行了首次TA-ESD与C-ESD的比较。方法:这是一项回顾性队列匹配研究,研究对象为在美国同一中心接受结肠ESD手术的所有患者。研究组是接受TA-ESD的患者,根据结肠内位置、病变大小和范围稳定装置的使用情况,以1:1的比例匹配C-ESD病例。比较两组患者的基线特征和手术相关结果。结果共纳入结肠ESD 138例,其中ta型ESD 69例,c型ESD 69例。两组间基线特征无显著差异。TA-ESD平均手术时间为91.0分钟(SD: 32.5), C-ESD平均手术时间为85.4分钟(SD: 39.3) (P = 0.36)。整体切除69例(100%)TA-ESDs和67例(97.1%)C-ESDs (P = 0.15)。52例TA-ESDs(75.4%)和48例C-ESDs(69.6%)实现R0切除(P = 0.45)。结论:我们在手术时间、整体切除、R0切除或不良事件方面没有显示出显著差异。为了进一步阐明该技术的实用性,需要进一步的随机前瞻性研究,这些研究需要有足够的动力,并根据操作人员的经验水平进行分层。
{"title":"Traction-Assisted Endoscopic Submucosal Dissection of Colonic Lesions: A North American Experience","authors":"Farid Abushamat,&nbsp;Fares Ayoub,&nbsp;Mai A. Khalaf,&nbsp;Tara Keihanian,&nbsp;Salmaan Jawaid,&nbsp;Mohamed O. Othman","doi":"10.1016/j.tige.2024.250900","DOIUrl":"10.1016/j.tige.2024.250900","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Traction-assisted endoscopic submucosal dissection (TA-ESD) is a proposed technique to improve the efficiency of endoscopic submucosal dissection (ESD). Multiple studies primarily from Asian centers yielded mixed results in terms of procedure time, en bloc resection rate, and R0 resection rate of TA-ESD in comparison with those of conventional endoscopic submucosal dissection (C-ESD). We performed the first comparison of TA-ESD with C-ESD at a high-volume North American center.</div></div><div><h3>METHODS</h3><div>This was a retrospective cohort-matched study of all patients who underwent colonic ESD at a single center in the United States by a single operator. The study group were patients who underwent TA-ESD and were matched with a C-ESD case on a 1:1 basis based upon location within the colon, lesion size, and scope stabilization device usage. The baseline characteristics and procedure-related outcomes were compared between the groups.</div></div><div><h3>RESULTS</h3><div>In total, 138 colonic ESD cases were included (69 TA-ESD and 69 C-ESD). There were no significant differences in the baseline characteristics between the groups. Mean procedure time was 91.0 minutes (SD: 32.5) for TA-ESD and 85.4 minutes (SD: 39.3) for C-ESD (<em>P</em> = 0.36). En bloc resection was achieved in 69 (100%) of the TA-ESDs and 67 (97.1%) of the C-ESDs (<em>P</em> = 0.15). R0 resection was achieved in 52 (75.4%) of the TA-ESDs and 48 (69.6%) of the C-ESDs (<em>P</em> = 0.45).</div></div><div><h3>CONCLUSION</h3><div>We did not show a significant difference in procedure time, en bloc resection, R0 resection, or adverse events. Further randomized prospective studies that are sufficiently powered and stratified by operator experience level are needed to further elucidate the utility of the technique.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 250900"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143158124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 封面
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-07-28 DOI: 10.1016/S2590-0307(25)00032-7
{"title":"Cover","authors":"","doi":"10.1016/S2590-0307(25)00032-7","DOIUrl":"10.1016/S2590-0307(25)00032-7","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250937"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144713651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reopenable Clip-Over-the-Line Method for Troubleshooting Iatrogenic Gastrointestinal Perforations 诊断医源性胃肠道穿孔的可重新打开夹过线方法
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-17 DOI: 10.1016/j.tige.2024.250901
Takeshi Yasuda, Narutoshi Ando, Tamae Hashimoto, Yoshiaki Kanai, Yoichi Sakamoto, Yuki Endo, Tomohiro Soda, Takako Akazawa, Tsuguhiro Matsumoto, Norihito Yamauchi, Akira Muramatsu, Hiromu Kutsumi
{"title":"Reopenable Clip-Over-the-Line Method for Troubleshooting Iatrogenic Gastrointestinal Perforations","authors":"Takeshi Yasuda,&nbsp;Narutoshi Ando,&nbsp;Tamae Hashimoto,&nbsp;Yoshiaki Kanai,&nbsp;Yoichi Sakamoto,&nbsp;Yuki Endo,&nbsp;Tomohiro Soda,&nbsp;Takako Akazawa,&nbsp;Tsuguhiro Matsumoto,&nbsp;Norihito Yamauchi,&nbsp;Akira Muramatsu,&nbsp;Hiromu Kutsumi","doi":"10.1016/j.tige.2024.250901","DOIUrl":"10.1016/j.tige.2024.250901","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 250901"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143158116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy and Safety of Needle-Knife Fistulotomy vs Standard Cannulation: A Practical Randomized Controlled Trial 针刀造瘘与标准插管的疗效和安全性比较:一项实用的随机对照试验
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-07-12 DOI: 10.1016/j.tige.2025.250941
Aleksey Novikov , Shuji Mitsuhashi , Muhammad Hassaan Bashir , Mena Bakhit , Ian Holmes , Alexander Schlachterman , Austin Chiang , David Loren , Thomas Kowalski

BACKGROUND AND AIMS

Current literature suggests that needle-knife fistulotomy (NKF) technique should be reserved for expert advanced endoscopists. The aim of this study was to evaluate the efficacy and safety of NKF compared with those of standard cannulation (SC) for primary biliary access performed by advanced endoscopists with a range of experience, including advanced endoscopy trainees.

METHODS

In total, 186 patients were randomly assigned to either NKF or SC as means of primary biliary access and 137 patients were included in the final analysis (clinicaltrials.gov; NCT06694038). The primary outcome was incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Secondary outcomes were biliary access success, time to biliary access, incidence of bleeding, and incidence of perforation.

RESULTS

Of the 137 procedures included in the study, 99 (72.3%) were carried out by advanced endoscopy trainees under supervision, 26 (19.0%) by advanced endoscopists without significant previous NKF experience, and 12 (8.8%) by an experienced advanced endoscopist with expertise in NKF. In the group that was randomized to SC, 6 (8.22%) patients developed pancreatitis vs 5 (7.81%) patients randomized to NKF arm (P = 0.93). Average time to biliary access within 20 minutes was significantly shorter with SC at 268 seconds (95% CI, 198-338 seconds) vs 380 seconds (95% CI, 292-466 seconds; P < 0.05) in the NKF arm.

CONCLUSION

NKF is a safe and effective technique for primary biliary access during ERCP performed by advanced endoscopists with a wide range of experience, with post-ERCP pancreatitis equivalent to SC. NKF, in this study, took slightly longer than SC to achieve bile duct access. Use of either or both techniques resulted in a 100% successful bile duct cannulation in patients with favorable anatomy.
背景和目的目前的文献表明针刀造瘘术(NKF)应该保留给高级内窥镜专家。本研究的目的是评估NKF与标准插管(SC)在初级胆道通路中的疗效和安全性,标准插管由具有丰富经验的高级内窥镜医师(包括高级内窥镜实习生)实施。方法共186例患者随机分配至NKF组或SC组作为初级胆道通路,137例患者被纳入最终分析(clinicaltrials.gov; NCT06694038)。主要结局是内镜后逆行胆管胰腺炎(ERCP)的发生率。次要结局是胆道通路的成功、到达胆道通路的时间、出血的发生率和穿孔的发生率。结果在纳入研究的137例手术中,99例(72.3%)由高级内窥镜培训生在监督下进行,26例(19.0%)由没有显著NKF经验的高级内窥镜医师进行,12例(8.8%)由具有NKF专业知识的经验丰富的高级内窥镜医师进行。在随机分配到SC组的患者中,6名(8.22%)患者发生胰腺炎,而随机分配到NKF组的患者中有5名(7.81%)患者发生胰腺炎(P = 0.93)。20分钟内到达胆道通路的平均时间显著缩短,SC组为268秒(95% CI, 198-338秒),而NKF组为380秒(95% CI, 292-466秒;P < 0.05)。结论在ERCP术后胰腺炎等同于SC的情况下,由经验丰富的高级内窥镜医师实施的NKF是一种安全有效的初级胆道通路技术。在本研究中,NKF比SC所需的时间稍长。在解剖结构良好的患者中,使用其中一种或两种技术均可100%成功地进行胆管插管。
{"title":"Comparative Efficacy and Safety of Needle-Knife Fistulotomy vs Standard Cannulation: A Practical Randomized Controlled Trial","authors":"Aleksey Novikov ,&nbsp;Shuji Mitsuhashi ,&nbsp;Muhammad Hassaan Bashir ,&nbsp;Mena Bakhit ,&nbsp;Ian Holmes ,&nbsp;Alexander Schlachterman ,&nbsp;Austin Chiang ,&nbsp;David Loren ,&nbsp;Thomas Kowalski","doi":"10.1016/j.tige.2025.250941","DOIUrl":"10.1016/j.tige.2025.250941","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Current literature suggests that needle-knife fistulotomy (NKF) technique should be reserved for expert advanced endoscopists. The aim of this study was to evaluate the efficacy and safety of NKF compared with those of standard cannulation (SC) for primary biliary access performed by advanced endoscopists with a range of experience, including advanced endoscopy trainees.</div></div><div><h3>METHODS</h3><div>In total, 186 patients were randomly assigned to either NKF or SC as means of primary biliary access and 137 patients were included in the final analysis (clinicaltrials.gov; NCT06694038). The primary outcome was incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Secondary outcomes were biliary access success, time to biliary access, incidence of bleeding, and incidence of perforation.</div></div><div><h3>RESULTS</h3><div>Of the 137 procedures included in the study, 99 (72.3%) were carried out by advanced endoscopy trainees under supervision, 26 (19.0%) by advanced endoscopists without significant previous NKF experience, and 12 (8.8%) by an experienced advanced endoscopist with expertise in NKF. In the group that was randomized to SC, 6 (8.22%) patients developed pancreatitis vs 5 (7.81%) patients randomized to NKF arm (<em>P</em> = 0.93). Average time to biliary access within 20 minutes was significantly shorter with SC at 268 seconds (95% CI, 198-338 seconds) vs 380 seconds (95% CI, 292-466 seconds; <em>P</em> &lt; 0.05) in the NKF arm.</div></div><div><h3>CONCLUSION</h3><div>NKF is a safe and effective technique for primary biliary access during ERCP performed by advanced endoscopists with a wide range of experience, with post-ERCP pancreatitis equivalent to SC. NKF, in this study, took slightly longer than SC to achieve bile duct access. Use of either or both techniques resulted in a 100% successful bile duct cannulation in patients with favorable anatomy.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 4","pages":"Article 250941"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Patients’ Current Acceptability of Artificial Intelligence During Colonoscopy for Polyp Detection: A Single-Center Study 了解患者目前在结肠镜检查息肉时对人工智能的接受程度:一项单中心研究
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-12-27 DOI: 10.1016/j.tige.2024.250905
Kathryn A. Schmidt , Shubham Sood , Saam Dilmaghani , Cadman Leggett , Ross Dierkhising , Mayank Goyal , Barbara A. Barry , Xuan Zhu , Nayantara Coelho-Prabhu

BACKGROUND AND AIMS

Research into potential applications of artificial intelligence (AI) in healthcare have witnessed a meteoric rise. A primary application in gastroenterological care is colonoscopy. Before AI tools become ubiquitous in healthcare, it is critical to appreciate the perspective of the potential beneficiaries, particularly patients. This study evaluated patient acceptability of AI in colonoscopy, particularly for polyp detection and diagnosis.

METHODS

In this cross-sectional survey study, patients undergoing outpatient colon cancer screening or surveillance colonoscopies at Mayo Clinic, Rochester, from September 2023 to February 2024 completed an electronic self-administered survey via tablet computer including questions regarding AI in colonoscopy. The primary outcome was patient perspectives on AI, and secondary outcomes included patient factors influencing their perspective. Statistical analyses were performed using Pearson's chi-square test and ordinal logistic regression.

RESULTS

Five hundred eight participants completed the survey. Younger age, male gender, and higher education were associated with higher AI familiarity and perceived importance, while males and those who believed in AI's positive outcomes were more comfortable with AI-assisted polyp detection.

CONCLUSION

This study is the first to assess patient perceptions of AI in colonoscopy. While patients generally believe AI can improve health outcomes, there is uncertainty about its current use, indicating a gap in knowledge and awareness. Key findings highlight that beliefs in AI's efficacy are linked to increased comfort with AI-assisted procedures, with significant demographic variations in perceptions, particularly across gender, age, and education. Addressing disparities through targeted education and transparent communication is crucial for fostering patient acceptance and trust in AI-assisted colonoscopy.
背景和目的人工智能(AI)在医疗保健领域的潜在应用研究正在迅速兴起。结肠镜检查是胃肠病学护理的主要应用。在人工智能工具在医疗保健领域普及之前,了解潜在受益者(尤其是患者)的观点至关重要。本研究评估了患者对人工智能在结肠镜检查中的可接受性,特别是对息肉的检测和诊断。方法在这项横断面调查研究中,2023年9月至2024年2月在罗切斯特梅奥诊所接受门诊结肠癌筛查或监测结肠镜检查的患者通过平板电脑完成了一项电子自我调查,包括结肠镜检查中人工智能的问题。主要结局是患者对人工智能的看法,次要结局包括影响其看法的患者因素。统计学分析采用皮尔逊卡方检验和有序逻辑回归。结果共有580名参与者完成了调查。年龄较小、男性性别和高等教育程度与人工智能的熟悉程度和感知重要性相关,而男性和那些相信人工智能积极结果的人对人工智能辅助息肉检测更满意。结论:本研究首次评估患者对结肠镜检查中人工智能的认知。虽然患者普遍认为人工智能可以改善健康状况,但其目前的用途存在不确定性,这表明在知识和意识方面存在差距。主要研究结果强调,对人工智能功效的信念与人工智能辅助手术的舒适度增加有关,在观念上存在显著的人口差异,特别是在性别、年龄和教育方面。通过有针对性的教育和透明的沟通来解决差异,对于促进患者对人工智能辅助结肠镜检查的接受和信任至关重要。
{"title":"Understanding Patients’ Current Acceptability of Artificial Intelligence During Colonoscopy for Polyp Detection: A Single-Center Study","authors":"Kathryn A. Schmidt ,&nbsp;Shubham Sood ,&nbsp;Saam Dilmaghani ,&nbsp;Cadman Leggett ,&nbsp;Ross Dierkhising ,&nbsp;Mayank Goyal ,&nbsp;Barbara A. Barry ,&nbsp;Xuan Zhu ,&nbsp;Nayantara Coelho-Prabhu","doi":"10.1016/j.tige.2024.250905","DOIUrl":"10.1016/j.tige.2024.250905","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Research into potential applications of artificial intelligence (AI) in healthcare have witnessed a meteoric rise. A primary application in gastroenterological care is colonoscopy. Before AI tools become ubiquitous in healthcare, it is critical to appreciate the perspective of the potential beneficiaries, particularly patients. This study evaluated patient acceptability of AI in colonoscopy, particularly for polyp detection and diagnosis.</div></div><div><h3>METHODS</h3><div>In this cross-sectional survey study, patients undergoing outpatient colon cancer screening or surveillance colonoscopies at Mayo Clinic, Rochester, from September 2023 to February 2024 completed an electronic self-administered survey via tablet computer including questions regarding AI in colonoscopy. The primary outcome was patient perspectives on AI, and secondary outcomes included patient factors influencing their perspective. Statistical analyses were performed using Pearson's chi-square test and ordinal logistic regression.</div></div><div><h3>RESULTS</h3><div>Five hundred eight participants completed the survey. Younger age, male gender, and higher education were associated with higher AI familiarity and perceived importance, while males and those who believed in AI's positive outcomes were more comfortable with AI-assisted polyp detection.</div></div><div><h3>CONCLUSION</h3><div>This study is the first to assess patient perceptions of AI in colonoscopy. While patients generally believe AI can improve health outcomes, there is uncertainty about its current use, indicating a gap in knowledge and awareness. Key findings highlight that beliefs in AI's efficacy are linked to increased comfort with AI-assisted procedures, with significant demographic variations in perceptions, particularly across gender, age, and education. Addressing disparities through targeted education and transparent communication is crucial for fostering patient acceptance and trust in AI-assisted colonoscopy.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250905"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Cleansing Solution for High-Quality Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial 一种用于高质量上消化道内镜检查的新型清洁溶液:一项多中心随机对照试验
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-08 DOI: 10.1016/j.tige.2025.250928
Noemi Gualandi , Giulia Gibiino , Giuliano Francesco Bonura , Matteo Secco , Paola Soriani , Alessandro Cucchetti , Cecilia Binda , Valentina Zadro , Pablo Cortegoso Valdivia , Paolo Biancheri , Mauro Manno , Carlo Fabbri

BACKGROUND AND AIMS

Esophagogastroduodenoscopy (EGD) is the gold standard examination for upper gastrointestinal (GI) disease diagnosis; however, intraluminal bubbles and mucus may reduce visibility. Mucolytic and tensioactive agents before EGD improve gastric visualization. We compared the efficacy of a novel cleansing preparation vs fasting on upper GI tract visualization during EGD.

METHODS

We conducted a multicenter, prospective, randomized controlled trial on consecutive adult outpatients undergoing EGD. Patients were randomized 1:1 to drink 50 mL of simethicone 150 mg, N-acetylcysteine 250 mg, and 10% acetic acid solution (Lumevis, Biofarmatec srl, Palermo, Italy) before the EGD or to fasting. The primary outcome was overall mucosal vision quality score, defined as the sum of 1-10 visual analog scale scores (0 = no visualization; 10 = perfect visualization) for each segment (esophagus, stomach, and duodenum) before washing. Secondary outcomes included adverse event rate, patient satisfaction, and EGD duration.

RESULTS

Patients were randomized to cleansing solution (n = 60) or fasting (n = 60). Cleansing preparation administration before EGD was associated with a higher overall mucosal vision quality score compared with fasting only (median visual analog scale score 23 [range, 21-25] vs 19 [range, 16-23], P = 0.001). No adverse events were reported in both groups. Patient satisfaction and EGD duration were similar between the cleansing preparation and fasting only.

CONCLUSION

Compared with fasting only, the administration of this novel cleansing solution was associated with improved mucosal visualization of the upper GI tract.
背景与目的食管胃十二指肠镜检查(EGD)是上消化道疾病诊断的金标准检查;然而,腔内气泡和粘液可能会降低能见度。EGD前使用粘液溶解剂和张力活性药物可改善胃显像。我们比较了一种新型清洁制剂与禁食对EGD期间上消化道显像的疗效。方法对连续接受EGD的成人门诊患者进行多中心、前瞻性、随机对照试验。患者按1:1的比例随机分配,在EGD前或禁食时饮用50 mL的西甲硅氧烷150 mg、n -乙酰半胱氨酸250 mg和10%的醋酸溶液(Lumevis, Biofarmatec srl, Palermo, Italy)。主要终点是粘膜视觉质量总分,定义为1-10个视觉模拟量表评分的总和(0 =无视觉;10 =完美的视觉效果)清洗前对每个节段(食道、胃和十二指肠)进行检查。次要结局包括不良事件发生率、患者满意度和EGD持续时间。结果患者随机分为洗液组(n = 60)和禁食组(n = 60)。与禁食相比,EGD前给予清洁制剂与更高的总体粘膜视觉质量评分相关(视觉模拟量表中位数评分为23[范围,21-25]对19[范围,16-23],P = 0.001)。两组均无不良事件发生。患者满意度和EGD持续时间在清洁制剂和禁食之间相似。结论:与单纯禁食相比,使用这种新型清洁液可改善上消化道粘膜的显像。
{"title":"A Novel Cleansing Solution for High-Quality Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial","authors":"Noemi Gualandi ,&nbsp;Giulia Gibiino ,&nbsp;Giuliano Francesco Bonura ,&nbsp;Matteo Secco ,&nbsp;Paola Soriani ,&nbsp;Alessandro Cucchetti ,&nbsp;Cecilia Binda ,&nbsp;Valentina Zadro ,&nbsp;Pablo Cortegoso Valdivia ,&nbsp;Paolo Biancheri ,&nbsp;Mauro Manno ,&nbsp;Carlo Fabbri","doi":"10.1016/j.tige.2025.250928","DOIUrl":"10.1016/j.tige.2025.250928","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Esophagogastroduodenoscopy (EGD) is the gold standard examination for upper gastrointestinal (GI) disease diagnosis; however, intraluminal bubbles and mucus may reduce visibility. Mucolytic and tensioactive agents before EGD improve gastric visualization. We compared the efficacy of a novel cleansing preparation vs fasting on upper GI tract visualization during EGD.</div></div><div><h3>METHODS</h3><div>We conducted a multicenter, prospective, randomized controlled trial on consecutive adult outpatients undergoing EGD. Patients were randomized 1:1 to drink 50 mL of simethicone 150 mg, N-acetylcysteine 250 mg, and 10% acetic acid solution (Lumevis, Biofarmatec srl, Palermo, Italy) before the EGD or to fasting. The primary outcome was overall mucosal vision quality score, defined as the sum of 1-10 visual analog scale scores (0 = no visualization; 10 = perfect visualization) for each segment (esophagus, stomach, and duodenum) before washing. Secondary outcomes included adverse event rate, patient satisfaction, and EGD duration.</div></div><div><h3>RESULTS</h3><div>Patients were randomized to cleansing solution (<em>n</em> = 60) or fasting (<em>n</em> = 60). Cleansing preparation administration before EGD was associated with a higher overall mucosal vision quality score compared with fasting only (median visual analog scale score 23 [range, 21-25] vs 19 [range, 16-23], <em>P</em> = 0.001). No adverse events were reported in both groups. Patient satisfaction and EGD duration were similar between the cleansing preparation and fasting only.</div></div><div><h3>CONCLUSION</h3><div>Compared with fasting only, the administration of this novel cleansing solution was associated with improved mucosal visualization of the upper GI tract.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250928"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144298000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Techniques and Innovations in Gastrointestinal Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1